A breeding male dog that is no longer performing as expected raises an immediate question about fertility. Owners often look first at the obvious: semen quality, libido, and mating behavior. What is frequently overlooked is the organ that sits quietly at the centre of all of these functions and can compromise every one of them without producing dramatic symptoms until the problem is well established.
The prostate gland is not a peripheral concern in the breeding male dog. It is central to reproductive function, intimately connected to urinary health, and one of the most commonly affected organs in intact male dogs as they age. Prostate disease is not one condition. It is a spectrum of conditions, each with different causes, different presentations, and different implications for both the dog’s health and its breeding viability.
Understanding this spectrum is what separates reactive management from proactive care.
What the Prostate Does, And Why It Matters in Breeding Dogs
The prostate gland is the only accessory sex gland in the male dog, located just caudal to the bladder and surrounding the urethra at its base. This anatomical position is both functionally important and the reason why prostate disease produces urinary symptoms as a consistent feature.
Its primary reproductive function is the secretion of prostatic fluid, which constitutes the majority of the volume of canine ejaculate. This fluid creates the transport medium for sperm, buffers the acidic environment of the female reproductive tract, and contains components that support sperm motility and viability. In a breeding male, the quality and composition of prostatic fluid directly affect the functional competence of the ejaculate.
When the prostate is diseased, the fluid it produces is altered. Inflammatory cells, bacteria, blood, or tumor products contaminate the prostatic fraction. The impact on sperm is direct and measurable: reduced motility, increased abnormal morphology, reduced viability, and in cases of acute infection, complete temporary loss of fertility.
What You May Notice, Early Signs of Prostate Trouble
The earliest signs of prostate disease in dogs are often urinary rather than reproductive, which leads many owners and even some vets to investigate the bladder and urethra before considering the prostate.
Straining to urinate, passing urine in smaller amounts than normal, or showing visible discomfort when urinating are common early presentations. Blood in the urine, whether noticed in the stream or as staining after the dog has finished, is a significant indicator. Difficulty passing stool, because the enlarged prostate compresses the rectum, is a sign that owners sometimes attribute to constipation. A ribbon-like or flattened stool shape is characteristic of rectal compression from prostatic enlargement.
Reduced libido, reluctance to complete mating, or painful ejaculation are the reproductive signs that eventually emerge in breeding males with established prostate disease. These signs typically appear later than the urinary ones, which is why a urinary presentation in an intact male dog should always prompt prostate assessment.
Why Prostate Disease Happens, The Underlying Causes
The prostate gland in intact male dogs is hormonally active throughout life, and that hormonal activity is the primary driver of most prostate conditions.
Testosterone and its metabolite dihydrotestosterone stimulate prostate cell growth throughout the dog’s life. In younger dogs, this produces a functional gland of appropriate size. As the dog ages, the cumulative effect of testosterone-driven stimulation causes progressive glandular enlargement. Estrogen, present in smaller quantities in male dogs, augments this effect. The result is benign prostatic hyperplasia, the most common prostate condition in intact male dogs, present to some degree in the majority of intact dogs by middle age.
Bacteria that enter the prostate through the urethra or through the bloodstream cause prostatitis. The enlarged, hyperplastic prostate may be more susceptible to bacterial colonization because of changes in its fluid composition and drainage. Prostatic cysts develop when glandular secretions accumulate without normal drainage. Tumors, both primary and arising from adjacent urothelial tissue, develop through independent mechanisms not reliably prevented by castration.
Related Videos
▶
▶
▶
▶Inside the Body: How Prostate Enlargement and Disease Develop
The hormonal mechanism that drives benign prostatic hyperplasia is progressive and cumulative.
As dihydrotestosterone binds to receptors in prostatic epithelial and stromal cells, it stimulates cell proliferation. The gland enlarges as cell numbers increase. In a normally functioning prostate, this growth is balanced by programmed cell death. In hyperplasia, proliferation outpaces normal turnover, and the gland accumulates volume progressively.
As the prostate enlarges, its relationship with surrounding structures changes. The urethra, which passes through the prostate, may be compressed, increasing urethral resistance and making urination progressively more difficult. The rectum, which lies dorsal to the prostate, is displaced by the enlarging gland, and the passage of stool becomes obstructed. Blood vessels within the enlarged gland become fragile, producing the intermittent hemorrhage that causes blood in the urine.
Inflammation from infection adds edema and inflammatory infiltrate to the already enlarged gland, accelerating the mechanical compression of adjacent structures. Cysts add further volume with discrete fluid-filled sacs that may be palpable on rectal examination.
Different Types of Prostate Disease, Not One Condition
The four main categories of prostatic disease in dogs each require a different clinical approach.
Benign prostatic hyperplasia is the most common and is directly hormone-driven. It is typically symmetric, produces gradual-onset urinary and defecation difficulties, and responds well to hormonal management or castration.
Prostatitis is a bacterial infection of the prostate, either acute or chronic. Acute prostatitis produces systemic illness, including fever, pain, and lethargy, alongside urinary signs. Chronic prostatitis may produce more subtle signs, including intermittent urinary or reproductive abnormalities, making diagnosis more challenging.
Prostatic cysts are fluid-filled structures either within the gland or adjacent to it. They may grow large enough to cause mechanical obstruction or become infected.
Prostatic neoplasia, including adenocarcinoma and transitional cell carcinoma, is the most serious category. It is locally invasive, tends to metastasize, and does not respond to the hormonal treatments that manage benign conditions.
How This Differs Across Conditions, A Critical Comparison
The clinical and therapeutic distinctions between these conditions are significant and justify careful diagnosis before treatment is initiated.
Benign prostatic hyperplasia produces symmetric enlargement in an intact male, causes gradual-onset urinary and defecation difficulty, does not cause systemic illness, and responds definitively to castration or anti-androgenic treatment. The full clinical picture of this condition, including its management, is covered in VOSD’s article on prostate enlargement in dogs.
Acute prostatitis produces systemic signs, including fever and severe pain, requires antibiotic treatment based on bacterial culture, and may require hospitalization in severe cases. It is not resolved by castration alone, though castration reduces the risk of recurrence.
Prostatic cysts may require surgical drainage or excision, particularly if they become infected or cause obstruction. Castration reduces the hormonal stimulus for cyst formation but does not drain existing cysts.
Prostatic adenocarcinoma does not respond to castration, may occur in neutered dogs, and is managed primarily with palliative intent. Treating a dog with adenocarcinoma as though it has benign hyperplasia wastes critical time.
This spectrum of conditions requires imaging and often biopsy for accurate classification, not empirical treatment based on an assumed diagnosis.
Impact on Breeding, Why Fertility Is Directly Affected
The prostate’s central role in ejaculate production means that any significant prostate disease affects semen quality in measurable ways.
In benign prostatic hyperplasia, the prostatic fluid fraction is increased in volume but may contain blood cells and altered protein composition that reduce sperm viability. Semen analysis in affected dogs typically shows increased numbers of abnormal sperm morphology and reduced motility.
In prostatitis, the ejaculate is directly contaminated with inflammatory cells and bacteria. Bacterial contamination of semen can cause infertility both through direct sperm damage and through transmission to breeding partners. A male dog with active prostatitis should not be used for breeding until the infection is confirmed to have resolved.
Painful prostate conditions cause reluctance to mount, painful ejaculation, and in severe cases, complete avoidance of mating behavior. A dog that has been willing to breed and then shows reluctance should have a prostate assessment before any assumption of psychological or behavioral cause is accepted.
How Urinary Symptoms Signal Prostate Problems
The connection between prostate disease and urinary symptoms is direct and anatomical. Any condition that enlarges or inflames the prostate has the potential to affect urinary function simply by its mechanical relationship to the urethra.
Difficulty urinating, frequency of urination, blood in urine, and painful urination are all consistent with prostate disease and should prompt prostate evaluation in any intact male dog. These signs are covered in depth in VOSD’s article on painful and frequent urination in dogs, which addresses the full differential diagnosis of these symptoms and the investigative approach to identifying their cause.
How Vets Diagnose Prostate Disease
Diagnosis begins with rectal palpation, which provides immediate information about the size, symmetry, consistency, and pain response of the prostate.
A symmetrically enlarged, non-painful prostate in a middle-aged to older intact male suggests benign hyperplasia. A painful prostate with systemic illness suggests prostatitis. An irregular, asymmetric, hard prostate with reduced mobility raises concern for neoplasia. Cysts may be palpable as fluctuant areas within or adjacent to the gland.
Ultrasound of the prostate provides a more detailed assessment of internal architecture, identifies discrete cysts, evaluates echogenicity changes consistent with inflammation or tumor, and guides fine-needle aspiration or biopsy when tissue sampling is needed. Semen analysis assesses prostatic fluid quality directly and identifies inflammatory cells or bacteria. Urine culture and bacterial culture of prostatic fluid identify the specific organism in prostatitis cases and guide antibiotic selection. Radiography assesses for bladder calculi, rectal displacement, and metastatic changes in the lumbar spine and pelvis.
Treatment Options, What Can Be Done for Each Condition
Treatment is determined by the specific condition identified.
Benign prostatic hyperplasia responds definitively to castration, which removes the androgenic stimulus for glandular growth. In dogs that must remain intact for breeding, hormonal management with anti-androgenic agents can reduce prostate size temporarily, though the effect is not permanent while testosterone is still produced. The breeding implications of any hormonal treatment on sperm quality must be considered.
Prostatitis requires antibiotic therapy based on culture and sensitivity, chosen for its ability to penetrate the prostatic blood-tissue barrier. Many antibiotics achieve inadequate prostatic concentrations despite appropriate serum levels. Fluoroquinolones and trimethoprim-sulfamethoxazole combinations are among the agents with good prostatic penetration. Treatment duration for chronic prostatitis may extend to four to eight weeks. Castration reduces recurrence risk.
Prostatic cysts are managed surgically if large or infected. Aspiration alone has a high recurrence rate. Castration reduces new cyst formation by removing the hormonal stimulus.
Prostatic adenocarcinoma is managed palliatively. Non-steroidal anti-inflammatory drugs with documented anti-tumor activity form the primary treatment, with chemotherapy in some cases. Castration does not benefit dogs with confirmed adenocarcinoma.
What Happens If You Ignore It, Long-Term Risks
Untreated prostate disease does not stabilize. Each condition has a natural history of progression that worsens over time.
Untreated benign hyperplasia leads to progressive urinary obstruction and increasing defecation difficulty. In severe cases, urinary retention can develop, producing a bladder that cannot be emptied and the systemic consequences of urinary stasis and potential bladder rupture.
Untreated prostatitis carries the risk of prostatic abscess formation, septicemia, and peritonitis if the abscess ruptures. Chronic low-grade prostatitis causes progressive reproductive impairment and may seed bacteria into the ejaculate persistently.
Untreated prostatic adenocarcinoma progresses to extensive local invasion and metastatic disease with severe pain, mobility loss, and systemic deterioration.
Neutering and Its Role, Prevention vs Impact on Breeding
Castration is the most effective preventive measure for the hormone-dependent prostate conditions that affect intact male dogs. It eliminates the androgenic stimulus that drives benign hyperplasia, reduces the risk of prostatitis recurrence, and eliminates the conditions that predispose to cyst formation.
For non-breeding dogs, the decision is straightforward. For breeding males, the prevention benefit of castration is irrelevant because it ends the dog’s reproductive capacity. The appropriate management for an intact breeding male with prostate disease is not castration but rather accurate diagnosis, condition-specific treatment, and a reassessment of whether continued breeding is medically appropriate given the nature and severity of the condition.
A dog with active prostatitis or significant benign hyperplasia affecting semen quality should have its breeding status reviewed. A dog with adenocarcinoma should not be used for breeding, regardless of clinical status.
When This Becomes an Emergency, Do Not Delay
Specific presentations of prostate disease require immediate emergency care.
Complete inability to urinate despite attempts is an acute emergency. Urethral obstruction secondary to severe prostatic enlargement or acute inflammation requires catheterization or other urgent intervention. A dog with acute prostatitis that is systemically collapsed, febrile, and showing abdominal pain may have a prostatic abscess requiring emergency surgery. Sudden severe hind limb weakness in a dog with known prostatic malignancy requires emergency spinal assessment.
None of these situations should be managed with watchful waiting at home.
When to See a Vet, Early Signs Matter in Breeding Dogs
Any intact male breeding dog that shows urinary changes, straining to defecate, changes in libido or mating behavior, or produces semen with blood, inflammatory cells, or reduced quality requires prostate assessment promptly. This is not a watchful waiting scenario. It is an investigation and diagnosis scenario.
Prostate conditions respond better to treatment at earlier stages. Benign hyperplasia that is identified and managed before it produces severe obstruction is more straightforward to address than a fully obstructed dog with bladder distension. Prostatitis identified at the acute stage responds more reliably to antibiotics than chronic prostatitis, where bacterial sequestration has occurred.
The broader landscape of conditions affecting male canine reproductive health is part of a wide clinical picture accessible through the VOSD library of dog medical conditions. For current developments in canine health management, dog health news provides ongoing updates on conditions affecting the dogs VOSD works with.









